Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/18626312

Download in:

View as

General Info

PMID
18626312